Dova Pharmaceuticals Announces European Union Marketing Authorization for DOPTELET® (avatrombopag) for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease June 25, 2019 - NASDAQ Companies 0 » View More News for June 25, 2019